Erlanger Kidney Transplant Center hires Dr. Alan Koffron as surgical director and more Chattanooga-area career moves

some text
Alan Koffron

Erlanger Kidney Transplant Center hires Dr. Alan Koffron as surgical director

Dr. Alan Koffron has been hired as the surgical director of the Erlanger Kidney Transplant Center. In his new role, Koffron will work alongside Dr. Kenneth Kokko, kidney transplant center program and medical director.

Both Koffron and Kokko will be responsible for quality initiatives within the program, maintenance of translation protocols and interaction with the global transplant community.

Koffron earned his medical degree from the University of Iowa College of Medicine. Following medical school, he completed residency training in general surgery at Chicago Medical School University of Health Sciences. Dr. Koffron completed two fellowships – a multiple-organ transplant surgery and hepatobiliary surgery fellowship at Northwestern University Medical School in Chicago and a pediatric liver transplant surgery and hepatobiliary surgery fellowship at Children’s Memorial Hospital in Chicago.

“Dr. Koffron is an incredibly accomplished individual and physician, and I

Read More

American Kidney Fund Announces Partnership with Tricida to Expand Education of Metabolic Acidosis in Patients with Kidney Disease

Press release content from Accesswire. The AP news staff was not involved in its creation.

ROCKVILLE, MD / ACCESSWIRE / October 22, 2020 / The American Kidney Fund (AKF) today announced a partnership with Tricida, Inc. to increase the understanding of chronic metabolic acidosis, a common complication of kidney disease that can cause serious effects, such as chronic kidney disease (CKD) progression, muscle atrophy and cardiac issues. Tricida’s support will allow AKF to develop and disseminate educational information about metabolic acidosis’ role in the progression of CKD.

“Complications of CKD, such as metabolic acidosis, create serious health problems, including patients’ kidney disease getting worse,” said LaVarne A. Burton, AKF president and CEO. “We are extraordinarily grateful to Tricida for its partnership in working with us to encourage patients to take metabolic acidosis management seriously.”

“Tricida is honored to partner with the American Kidney Fund on this

Read More